HIV & AIDS

Gender, race, and HIV therapy: Insights from the GRACE study

Enrollment of women in clinical trials of new anti-HIV drugs is extremely low, representing only about 15% of all treatment-experienced patients. For women of color it is even lower. Why women, and especially women of color, ...

Diseases, Conditions, Syndromes

Experimental drug may work against hepatitis C

(HealthDay)—An experimental therapy for hepatitis C—a "silent killer" linked to liver cancer and cirrhosis—has shown promise in tamping down virus levels in early trials.

Neuroscience

Uncovering how humans hear one voice among many

Humans have an uncanny ability to zero in on a single voice, even amid the cacophony of voices found in a crowded party or other large gathering of people. Researchers have long sought to identify the precise mechanisms by ...

HIV & AIDS

HIV 'cure' in infancy, caution experts

AIDS experts cautioned Monday against hype of a cure after doctors in the United States suppressed HIV in a child born with the virus by administering a potent drug cocktail shortly after birth.

Medical research

New breakthrough could help treat muscular dystrophy

A researcher in the Faculty of Medicine & Dentistry at the University of Alberta improved Duchenne muscular dystrophy symptoms in non-human lab models, using a new drug cocktail. The drug combination targets the “hot ...

Psychology & Psychiatry

Alcohol is a social lubricant, study confirms

(HealthDay) -- You've seen those commercials with fun-loving people sharing a laugh over a cold brew. Now, a new study lends scientific support to the notion of alcohol as a social icebreaker.

Oncology & Cancer

Drug cocktail boosts ovarian cancer survival time

A drug cocktail that combines chemotherapy with Avastin was shown to double the amount of time patients lived without progression of ovarian cancer, according to research released Saturday.

page 4 from 5